Tepmetko is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping, who require systemic therapy following prior treatment
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors
Subscribe To Our Newsletter & Stay Updated
